Arulalan Monisha J, Dorairajan Gowri, Mondal Nivedita, Chinnakali Palanivel
Department of Obstetrics and Gynecology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry. India.
Department of Neonatology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
J Mother Child. 2022 Apr 18;25(4):260-268. doi: 10.34763/jmotherandchild.20212504.d-21-00034. eCollection 2021 Dec 1.
The literature on neonatal outcomes in preterm twins delivered before 34 weeks but within and after 14 days of a single initial steroid course is limited.
This bidirectional (226 prospective and 42 retrospectives) cohort study was performed at a tertiary care teaching hospital in South India. We compared the respiratory distress syndrome and neonatal death amongst preterm twins from 28 to 34 weeks born < 14 days (Group A, n=268) and after 14 days (Group B, n=268) of completion of a single course of antenatal steroids. We used multivariable regression analysis (log-binomial model) to adjust for confounding variables. We generated a propensity-matched score with probit regression to analyse outcomes (respiratory distress and neonatal deaths).
The two groups had significant differences in the distribution of birthweight, gestation period and mode of delivery. On adjusted analysis, the period of gestation below 33 weeks and weight below 1.5 kg had the maximum influence on respiratory and other morbidities, and weight less than 1 kg on neonatal death. [adjusted relative risk (ARR) 26.06, (95%CI=2.37-285.5), p=0.008]. On propensity scoring after matching all these variables, we found an [ARR of 2.0 (95% CI: 1.03-3.88), P=0.017] for neonatal death after 14 days of steroid injection. The ARR for respiratory distress syndrome was 1.13 in those born after 14 days of steroids, though it did not reach statistical significance.
On propensity scoring, the steroid-delivery interval more than 14 days was associated with a significantly increased risk (ARR of 2) of neonatal death.
关于孕周小于34周但在单次初始类固醇疗程的14天内及之后分娩的早产双胞胎的新生儿结局的文献有限。
这项双向(226例前瞻性和42例回顾性)队列研究在印度南部的一家三级护理教学医院进行。我们比较了28至34周出生的早产双胞胎在完成单次产前类固醇疗程后<14天(A组,n = 268)和14天后(B组,n = 268)的呼吸窘迫综合征和新生儿死亡情况。我们使用多变量回归分析(对数二项模型)来调整混杂变量。我们通过概率回归生成倾向匹配分数以分析结局(呼吸窘迫和新生儿死亡)。
两组在出生体重、孕周和分娩方式的分布上存在显著差异。经调整分析,孕周低于33周和体重低于1.5千克对呼吸及其他疾病影响最大,体重低于1千克对新生儿死亡影响最大。[调整相对风险(ARR)26.06,(95%置信区间=2.37 - 285.5),p = 0.008]。在对所有这些变量进行匹配后的倾向评分中,我们发现类固醇注射14天后新生儿死亡的[ARR为2.0(95%置信区间:1.03 - 3.88),P = 0.017]。类固醇注射14天后出生的婴儿呼吸窘迫综合征的ARR为1.13,尽管未达到统计学显著性。
在倾向评分中,类固醇给药间隔超过14天与新生儿死亡风险显著增加(ARR为2)相关。